SENTINEXT THERAPEUTICS ApS: Financial statements 2013
CVR: 32473016
Source: annual report 2013, Danish Business Authority
01/01/2013 – 30/10/2013
SENTINEXT THERAPEUTICS ApS (CVR 32473016) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 762,450 and a net result of DKK 36,765 compared with DKK 20,007 the year before. That is a decrease of 45.7% compared with the year before. Equity in the 2013 report amounted to DKK 122,610. The solvency ratio was 34%.
- Gross Profit
- DKK 762,450
- Profit/Loss
- DKK 36,765
- Equity
- DKK 122,610
- Total Assets
- DKK 360,350
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 762 t. | 37 t. | 123 t. | - |
| 2012 | - | 1.4 mio. | 20 t. | 86 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
As of November 15, 2013, Investeringsselskabet af 20. september 2008 ApS has stepped down as auditor of SENTINEXT THERAPEUTICS ApS.
As of November 15, 2013, Flemming Eske Hansen has stepped down as liquidator of SENTINEXT THERAPEUTICS ApS.
On November 15, 2013, SENTINEXT THERAPEUTICS ApS exited liquidation.
SENTINEXT THERAPEUTICS ApS was dissolved on November 15, 2013.
SENTINEXT THERAPEUTICS ApS has published its annual report for 2012. Gross profit came to DKK 1,404,825, and the net result was DKK 20,007.
As of March 19, 2013, Flemming Eske Hansen is registered as liquidator of SENTINEXT THERAPEUTICS ApS.
As of March 19, 2013, Peter Samuel Wulff has stepped down as direktion of SENTINEXT THERAPEUTICS ApS.
On March 19, 2013, SENTINEXT THERAPEUTICS ApS entered liquidation.
About SENTINEXT THERAPEUTICS ApS
SENTINEXT THERAPEUTICS ApS was a Danish company of the type Anpartsselskab based in København K, founded in 2009. The company has been dissolved on 15 November 2013. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees (2013). In 2013, the company reported a gross profit of DKK 762,450 and a net result of DKK 36,765 compared with DKK 20,007 the year before. Equity in the 2013 report amounted to DKK 122,610.